VANGUARD GROUP INC - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 86 filers reported holding SPERO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,884,691
-14.9%
1,557,596
+2.0%
0.00%
Q2 2023$2,213,387
+7.0%
1,526,474
+7.0%
0.00%
Q1 2023$2,068,528
+13.4%
1,426,571
+35.3%
0.00%
Q4 2022$1,824,091
-13.4%
1,054,388
+0.1%
0.00%
Q3 2022$2,107,000
+128.0%
1,053,723
-15.4%
0.00%
Q2 2022$924,000
-92.3%
1,245,992
-9.3%
0.00%
Q1 2022$11,953,000
-44.8%
1,373,928
+1.7%
0.00%
Q4 2021$21,636,000
-9.1%
1,351,378
+4.6%
0.00%
-100.0%
Q3 2021$23,794,000
+33.5%
1,292,498
+1.2%
0.00%
Q2 2021$17,824,000
+9.4%
1,276,790
+15.4%
0.00%
Q1 2021$16,292,000
-25.7%
1,106,696
-2.1%
0.00%
-100.0%
Q4 2020$21,925,000
+111.5%
1,130,730
+21.7%
0.00%
Q3 2020$10,366,000
+4.2%
928,898
+26.3%
0.00%
Q2 2020$9,948,000
+95.8%
735,234
+17.0%
0.00%
Q1 2020$5,080,000
+6.4%
628,588
+26.6%
0.00%
Q4 2019$4,773,000
-9.3%
496,401
-0.1%
0.00%
Q3 2019$5,265,000
+4.6%
496,687
+13.6%
0.00%
Q2 2019$5,032,000
-6.1%
437,204
+4.5%
0.00%
Q1 2019$5,359,000
+435.9%
418,390
+157.4%
0.00%
Q4 2018$1,000,000
-79.1%
162,564
-64.3%
0.00%
Q3 2018$4,787,000
+161.4%
455,416
+264.8%
0.00%
Q2 2018$1,831,000
+15.7%
124,836
+12.4%
0.00%
Q1 2018$1,582,000
+196.3%
111,039
+144.1%
0.00%
Q4 2017$534,00045,4890.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,376,968$13,247,00023.08%
Aquilo Capital Management, LLC 1,154,356$11,099,0004.17%
VHCP Management II, LLC 474,015$4,558,0001.20%
AWM Investment Company, Inc. 474,344$4,561,0000.89%
Alphabet Inc. 1,112,473$10,696,0000.65%
BVF INC/IL 845,405$8,129,0000.62%
Novo Holdings A/S 931,099$8,948,0000.58%
Artal Group S.A. 500,000$4,808,0000.19%
Rock Springs Capital Management LP 525,000$5,048,0000.16%
Granahan Investment Management 148,867$1,431,0000.07%
View complete list of SPERO THERAPEUTICS INC shareholders